MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
- Revenue, 2025
- $521M
- YoY, 2025
- +54.7%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $521M | +54.7% |
| 2024 | $337M | +80.8% |
| 2023 | $186M | +141.8% |
| 2022 | $77M | +302.7% |
| 2021 | $19M | — |
| 2020 | $0 | — |